Date: March 27, 2024

To
National Stock Exchange of India Limited
Exchange Plaza, Bandra Kurla Complex
Bandra (E), Mumbai - 400 051.

Subject: Change in the Status of Subsidiary company of Kotyark Industries Limited - Kotyark Bio
Specialities Ltd.- Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015.

Ref: Kotyark Industries Limited (Symbol:-KOTYARK)

---------------------------------------------------------------------------------------------------------------------------------
Dear Sir/Madam,

In terms of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015,
we would like to inform you, regarding change in the subsidiary company status of M/s. Kotyark Bio
Specialities Limited. , previously classified as our wholly-owned subsidiary company, Kotyark Bio
Specialities Limited has undergone changes in its ownership structure.

In the Meeting of the Board of Directors of Our wholly owned subsidiary company Kotyark Bio
Specialities Limited held on today i.e. March 27, 2024 it was duly considered and approved the issue and
allot 15,479 (Fifteen Thousand Four Hundred Seventy Nine) Compulsory Convertible Debentures
(hereinafter referred to as "CCD") of face value of Rs. 4175 each (Rupees Four thousand One Hundred
Seventy Five Only) aggregating to Rs. 6,46,24,825.00 (Rupees Six Crores Forty Six Lacs Twenty Four
Thousand Eight Hundred Twenty Five Only) on preferential basis through private placement to the public.
The same offer was approved by shareholders of the company at their meeting held on Wednesday, March
13, 2024.

The holders of Compulsory convertible Debentures shall possess the right to convert all or part of the
compulsory convertible Debentures held by them into Equity Shares at any point of time commencing
after the completion of 06 months from the date of allotment of CCD till expiry of 10 years from the date
of allotment, each CCDs Issue Price of Rs. 4175 each will be converted into such number of Equity Shares
based on higher of (i) Face value of Rs. 4175 each or (ii) Fair value of Equity Shares derived as per Rule 11
UA of Income Tax, at the time of conversion.

Consequently, the stake of Kotyark Industries Limited in the shareholding of Kotyark Bio Specialities
Limited has reduced below 100%. As a result, Kotyark Bio Specialities Limited will no longer be
considered a wholly-owned subsidiary company of our company. However, it will continue to be classified
as a subsidiary company of Kotyark Industries Limited.

This is for your information and records.

Thanking you,

Yours faithfully,

For, Kotyark Industries Limited

Digitally signed
BHAVESH by BHAVESH
BACHUBH BACHUBHAI
NAGAR
AI NAGAR Date: 2024.03.27
19:43:44 +05'30'

Bhavesh Nagar
Company Secretary and Compliance Officer
Mem. No.: A62546